Condition
    Moderate Evidence
    Effectiveness 3/5

    Probiotics for Stomach Pain

    Probiotic evidence in abdominal pain is strain-specific rather than category-wide. A handful of strains show small improvements in IBS pain scores; most multi-strain retail products have never been tested.

    Overview

    Probiotic evidence in abdominal pain is strain-specific rather than category-wide. A handful of strains show small improvements in IBS pain scores; most multi-strain retail products have never been tested.

    Verdict

    Mixed evidence

    Some specific strains modestly reduce functional abdominal pain, but benefits do not generalise across products and effect sizes are small.

    How It Works

    Proposed mechanisms include competitive exclusion of gas-producing organisms, modulation of visceral hypersensitivity via gut-brain signalling, tightening of epithelial barrier function, and shifts in short-chain fatty acid production.

    Dosing & Protocol

    Typical dose

    Recommended dose
    Strain-specific; typically 1-10 billion CFU daily of a studied strain
    Expected timeframe
    Four weeks is a reasonable trial period.

    Protocol

    form
    Single product with published trial data for its exact strain
    notes
    Stop if no clear change rather than cycling through products
    duration
    4 weeks
    starting dose
    As per the studied strain, commonly 1-10 billion CFU daily

    Evidence

    What the studies say

    Meta-analyses of probiotics in IBS consistently show statistically significant but small improvements in global symptoms and pain, with substantial heterogeneity between trials. Bifidobacterium infantis 35624 and certain Lactobacillus preparations have the most supportive data. Guideline bodies including the American College of Gastroenterology have declined to recommend probiotics generally for IBS because the strain-level evidence is too inconsistent to extrapolate.

    Comparative efficacy of probiotic, prebiotic, and synbiotic interventions in children with functional abdominal pain disorders: a systematic review and network meta-analysis

    Score: 7/10
    2026
    meta_analysis

    Yang Y, Li Y, Yan X +1 more

    Given their biological plausibility, probiotics have emerged as a promising therapy, yet evidence remains inconsistent due to strain-specific effects and heterogeneous study designs.

    View source

    Safety

    Caveats

    Transient bloating in the first week is common. Avoid live probiotics in severe immunosuppression, central venous lines or critical illness. Product quality and viable counts vary widely between brands.

    Less likely to help if

    People with post-infectious or constipation-dominant patterns often see less benefit; those with structural disease see none.

    Medical Disclaimer

    The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

    Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.